Skip to main content
logo
Alivus Life Sciences Limited (BOM:543322)
India flag India · Delayed Price · Currency is INR
1,095.45
-24.25 (-2.17%)
At close: Jul 30, 2026

Alivus Life Sciences Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
5,6454,8564,7094,6704,187
Depreciation & Amortization
753.57583.42497.78406.48369.2
Other Amortization
-22.6736.7414.469.57
Loss (Gain) From Sale of Assets
5.423.0210.115.587.43
Loss (Gain) From Sale of Investments
-380.56-76.1531.66--
Stock-Based Compensation
--43.7531.8534.98
Provision & Write-off of Bad Debts
---3.7148.19
Other Operating Activities
916.3309.79147.0364.97320.84
Change in Accounts Receivable
-887.54-2,048378.6-1,336-592.15
Change in Inventory
-674.47-388.55-826.26-972.27-28.23
Change in Accounts Payable
-126.77187.46-341.21907.79737.49
Change in Other Net Operating Assets
403.37445.2-551.93-735.63881.29
Operating Cash Flow
5,6543,9154,1353,0605,976
Operating Cash Flow Growth
44.41%-5.32%35.13%-48.79%53.97%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-3,071-1,662-1,290-1,628-1,322
Sale of Property, Plant & Equipment
6.476.294.651.744.69
Investment in Securities
-2,647-4,701-1.1128.05
Other Investing Activities
9.66200.13120.21157.6666.7
Investing Cash Flow
-5,702-6,156-1,165-1,467-1,222

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Repaid
-----9,329
Long-Term Debt Repaid
-80.21-44.86-22.09-11.28-13.65
Total Debt Repaid
-80.21-44.86-22.09-11.28-9,342
Net Debt Issued (Repaid)
-80.21-44.86-22.09-11.28-9,342
Issuance of Common Stock
103.946.69--10,119
Common Dividends Paid
-613.41--2,757-3,859-1,287
Other Financing Activities
-53.72-24.14-15.46-5.47-277.64
Financing Cash Flow
-643.4-62.31-2,794-3,876-787.96

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash Flow
-690.8-2,304175.91-2,2833,966

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
2,5842,2532,8451,4324,654
Free Cash Flow Growth
14.65%-20.81%98.69%-69.23%45.39%
Free Cash Flow Margin
10.12%9.44%12.46%6.63%21.92%
Free Cash Flow Per Share
21.0118.3423.1911.6939.60
Levered Free Cash Flow
1,7131,3902,108553.753,756
Unlevered Free Cash Flow
1,7471,4052,117557.173,931

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
53.7224.1415.465.47277.64
Cash Income Tax Paid
1,7331,6301,6301,5361,382
Change in Working Capital
-1,285-1,804-1,341-2,137998.4